WHO issues alert over India-made cough syrup Guaifenesin
Tags: International News
The WHO has issued a red alert due to "unacceptable amounts of diethylene glycol and ethylene glycol" in the tested samples of Guaifenesin TG syrup manufactured by Punjab-based QP Pharmachem Ltd.
An overview of the news
The World Health Organization has said that a consignment of this contaminated cough syrup made in India has been found in the Marshall Islands and Micronesia.
Guaifenesin is used to relieve the symptoms of cough and tightness in the chest.
Samples of Guaifenesin Syrup TG Syrup from the Marshall Islands were analyzed and it was found that the product contained unacceptable amounts of Diethylene Glycol and Ethylene Glycol as contaminants.
Ingestion of diethylene glycol and ethylene glycol aretoxic to humans, and can prove fatal.
The latest alert comes months after the WHO linked another cough syrup made in India to child deaths in Gambia and Uzbekistan.
India is the world's largest exporter of generic drugs, which meet most of the medical needs of developing countries.
But in recent months, several Indian companies have come under scrutiny for the quality of their drugs, with experts raising concerns about the manufacturing practices used to make these drugs.
Please Rate this article, so that we can improve the quality for you -